Hsp70-targeting Chimeras

Hsp70 is a conserved molecular chaperone that stabilizes protein substrates against denaturation or aggregation and supports protein folding, transport, complex remodeling, and degradation of unwanted proteins^[1]. Mechanistically, stress-inducible HSPA1A/Hsp72 and constitutive HSPA8/Hsc70 operate in the cytosol and nucleus, whereas HSPA5/BiP functions in the endoplasmic reticulum and HSPA9/mortalin functions in mitochondria^[1]. In heat-stressed breast cancer cells, HSPA1 promotes 26S proteasome recruitment to translating ribosomes and maintains ubiquitylated nascent proteins in a soluble state for proteasomal clearance^[2]. Disease relevance is supported by cancer and neurodegeneration studies, including hepatocellular carcinoma analyses linking high HSPA1A, HSPA5, and HSPA8 expression with poorer survival variables^[3]. Compared with related isoforms, human Hsp70 substrate-binding domains recognize distinct client proteins, and Hsp70 chimeras show divergent heat-shock complementation, supporting isoform-specific inhibitor design^[4]. For experimental applications, VER-155008 inhibits Hsp70 through the nucleotide-binding domain but is not isoform-specific, so Hsp70-targeting chimera studies should prioritize isoform-selective binders and substrate-binding-domain differences^[5].